ctrl K

Price Alert

ImmunoPrecise Antibodies ... (IPA)

NASDAQ: IPA · Real-Time Price · USD

2.71

0.71 (35.50%)

At close: Aug 18, 2025, 3:59 PM

2.75

1.48%

Pre-market: Aug 19, 2025, 04:12 AM EDT

ImmunoPrecise Antibodies Income Statement

Financials in CAD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Revenue	24.52M	24.52M	20.66M	19.36M	17.91M
Cost of Revenue	10.97M	12.46M	9.1M	8.38M	6.37M
Gross Profit	13.55M	12.05M	11.56M	10.98M	11.54M
Operating Income	-12.2M	-13.76M	-25.61M	-15.78M	-4.18M
Interest Income	n/a	23K	122K	279K	282K
Pretax Income	-34.27M	-28.7M	-27.75M	-15.85M	-6M
Net Income	-30.23M	-27.18M	-26.56M	-16.71M	-7.34M
Selling & General & Admin	19.03M	19.14M	18.99M	17.71M	13.34M
Research & Development	4.94M	4.06M	14.11M	6.69M	1.97M
Other Expenses	1.77M	2.62M	4.08M	1.94M	475K
Operating Expenses	25.74M	25.82M	37.17M	27.66M	15.71M
Interest Expense	293K	19K	30K	85K	863K
Selling & Marketing Expenses	4.3M	3.54M	3.61M	740K	691K
Cost & Expenses	36.72M	38.28M	46.28M	35.53M	22.09M
Income Tax Expense	-4.03M	-1.53M	-1.19M	861K	1.34M
Shares Outstanding (Basic)	33.38M	25.64M	24.9M	19.69M	16.47M
Shares Outstanding (Diluted)	33.38M	25.64M	24.9M	19.69M	16.47M
EPS (Basic)	-0.91	-1.06	-1.07	-0.85	-0.45
EPS (Diluted)	-0.91	-1.06	-1.07	-0.85	-0.45
EBITDA	-28.86M	-22.95M	-21.04M	-11.99M	-1.42M
EBIT	-33.97M	-28.68M	-27.72M	-15.76M	-5.13M
Depreciation & Amortization	5.12M	5.74M	6.68M	3.77M	3.71M